Bank of America
TXG icon

Bank of America’s 10x Genomics TXG Stock Holding History

Bank of America’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.5M Sell
964,579
-872,941
-48% -$17.5M ﹤0.01% 2371
2025
Q4 		$30M Sell
1,837,520
-1,575,766
-46% -$23.8M ﹤0.01% 1949
2025
Q3 		$39.9M Buy
3,413,286
+389,797
+13% +$5.08M ﹤0.01% 1944
2025
Q2 		$35M Buy
3,023,489
+356,100
+13% +$3.25M ﹤0.01% 2011
2025
Q1 		$23.3M Buy
2,667,389
+2,012,390
+307% +$25.4M ﹤0.01% 2282
2024
Q4 		$9.41M Sell
654,999
-281,259
-30% -$4.44M ﹤0.01% 3008
2024
Q3 		$21.1M Buy
936,258
+199,760
+27% +$4.13M ﹤0.01% 2354
2024
Q2 		$14.3M Buy
736,498
+96,666
+15% +$2.53M ﹤0.01% 2570
2024
Q1 		$24M Buy
639,832
+370,884
+138% +$16.3M ﹤0.01% 2094
2023
Q4 		$15.1M Sell
268,948
-9,689
-3% -$422K ﹤0.01% 2436
2023
Q3 		$11.5M Buy
278,637
+50,152
+22% +$2.61M ﹤0.01% 2593
2023
Q2 		$12.8M Sell
228,485
-157,361
-41% -$8.52M ﹤0.01% 2468
2023
Q1 		$21.5M Sell
385,846
-321,439
-45% -$15M ﹤0.01% 2052
2022
Q4 		$25.8M Sell
707,285
-33,896
-5% -$1.11M ﹤0.01% 1804
2022
Q3 		$21.1M Buy
741,181
+213,202
+40% +$8.12M ﹤0.01% 1904
2022
Q2 		$23.9M Sell
527,979
-100,295
-16% -$5.2M ﹤0.01% 1849
2022
Q1 		$47.8M Buy
628,274
+274,341
+78% +$24M ﹤0.01% 1401
2021
Q4 		$52.7M Sell
353,933
-22,863
-6% -$3.5M 0.01% 1378
2021
Q3 		$54.9M Buy
376,796
+23,762
+7% +$4.08M 0.01% 1288
2021
Q2 		$69.1M Buy
353,034
+40,969
+13% +$7.41M 0.01% 1163
2021
Q1 		$56.5M Buy
312,065
+62,820
+25% +$10.8M 0.01% 1211
2020
Q4 		$35.3M Sell
249,245
-35,597
-12% -$5.17M ﹤0.01% 1422
2020
Q3 		$35.5M Buy
284,842
+28,608
+11% +$3M ﹤0.01% 1281
2020
Q2 		$22.9M Buy
256,234
+184,255
+256% +$14.4M ﹤0.01% 1523
2020
Q1 		$4.49M Buy
71,979
+69,867
+3,308% +$5.45M ﹤0.01% 2762
2019
Q4 		$161K Buy
2,112
+2,037
+2,716% +$122K ﹤0.01% 5752
2019
Q3 		$4K Buy
+75
New +$4.15K ﹤0.01% 6901

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's TXG Position: Q1 2026 in Review

Bank of America reduced its 10x Genomics (TXG) stake by 48% in Q1 2026, selling an estimated $17.5M and leaving 964,579 shares worth $20.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Bank of America first reported a position in TXG in Q3 2019 and has held it in 27 quarters since. The position peaked at $69.1M in Q2 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Bank of America held 964,579 shares of 10x Genomics worth $20.5M as of Q1 2026.
  • Bank of America sold 872,941 10x Genomics shares in Q1 2026, an estimated $17.5M.
  • 10x Genomics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2371 holding.
  • Bank of America first reported a position in 10x Genomics in Q3 2019 and has held it in 27 quarters since.
  • Bank of America's 10x Genomics position peaked at $69.1M in Q2 2021.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.